Your browser is no longer supported. Please, upgrade your browser.
Settings
CLSN Celsion Corporation daily Stock Chart
CLSN [NASD]
Celsion Corporation
Index- P/E- EPS (ttm)-0.75 Insider Own1.29% Shs Outstand33.88M Perf Week-4.26%
Market Cap26.31M Forward P/E- EPS next Y-0.39 Insider Trans0.00% Shs Float32.75M Perf Month-26.83%
Income-19.00M PEG- EPS next Q-0.13 Inst Own17.30% Short Float4.28% Perf Quarter-82.53%
Sales0.50M P/S52.62 EPS this Y-14.20% Inst Trans38.26% Short Ratio0.53 Perf Half Y-12.85%
Book/sh0.81 P/B0.96 EPS next Y38.10% ROA-46.10% Target Price- Perf Year-54.38%
Cash/sh0.75 P/C1.03 EPS next 5Y- ROE-107.80% 52W Range0.69 - 6.50 Perf YTD-54.64%
Dividend- P/FCF- EPS past 5Y47.50% ROI-76.80% 52W High-88.07% Beta2.01
Dividend %- Quick Ratio2.90 Sales past 5Y0.00% Gross Margin- 52W Low12.98% ATR0.06
Employees29 Current Ratio2.90 Sales Q/Q0.00% Oper. Margin- RSI (14)33.49 Volatility5.56% 8.40%
OptionableYes Debt/Eq0.41 EPS Q/Q37.60% Profit Margin- Rel Volume0.16 Prev Close0.77
ShortableYes LT Debt/Eq0.23 EarningsAug 14 BMO Payout- Avg Volume2.63M Price0.78
Recom2.30 SMA20-9.99% SMA50-24.17% SMA200-52.29% Volume433,342 Change0.73%
Jul-16-20Downgrade Oppenheimer Outperform → Perform
Jul-14-20Downgrade Dawson James Buy → Neutral
Oct-04-17Upgrade Maxim Group Hold → Buy $7
Apr-10-17Resumed Rodman & Renshaw Buy $1.50
Nov-10-16Downgrade Maxim Group Buy → Hold
Jul-12-16Resumed H.C. Wainwright Buy $3
Jan-19-16Reiterated Maxim Group Buy $12 → $9
Jul-15-15Initiated Maxim Group Buy $12
Jan-10-14Resumed HC Wainwright Buy $5 → $8
Aug-16-12Reiterated Griffin Securities Buy $10 → $18
Feb-16-12Initiated Brean Murray Buy $7
Oct-26-11Initiated Rodman & Renshaw Mkt Outperform $6
Nov-11-09Initiated Needham Buy $7
Sep-08-20 08:35AM  
Sep-02-20 08:00AM  
Aug-14-20 08:48AM  
08:00AM  
Aug-07-20 08:30AM  
Aug-04-20 08:30AM  
Jul-27-20 08:30AM  
Jul-21-20 08:56AM  
Jul-17-20 10:26PM  
Jul-14-20 10:49AM  
08:30AM  
Jul-13-20 08:30AM  
Jun-27-20 08:18PM  
Jun-25-20 08:00AM  
Jun-24-20 04:15PM  
09:39AM  
Jun-22-20 03:00PM  
Jun-17-20 08:43AM  
May-29-20 08:30AM  
May-15-20 08:00AM  
May-08-20 09:00AM  
Apr-23-20 08:30AM  
Apr-17-20 10:04AM  
Apr-15-20 08:30AM  
Apr-04-20 06:13AM  
Mar-26-20 09:00AM  
08:00AM  
Mar-25-20 04:15PM  
Mar-23-20 08:00AM  
Mar-19-20 08:30AM  
08:00AM  
Mar-03-20 08:30AM  
Feb-28-20 08:45AM  
Feb-25-20 06:20AM  
Feb-06-20 09:25AM  
Feb-04-20 08:30AM  
Jan-20-20 05:41AM  
Jan-15-20 04:34PM  
08:22AM  
Jan-14-20 08:53AM  
Jan-09-20 04:47PM  
Jan-07-20 09:59AM  
09:19AM  
Dec-23-19 02:15PM  
Dec-18-19 08:00AM  
Dec-17-19 08:00AM  
Dec-15-19 08:10AM  
Nov-30-19 01:48AM  
Nov-14-19 04:05PM  
08:00AM  
Nov-09-19 08:40AM  
Nov-08-19 08:30AM  
Nov-05-19 08:00AM  
Nov-04-19 08:00AM  
Oct-04-19 07:52AM  
Oct-01-19 08:00AM  
Sep-30-19 02:30PM  
Sep-23-19 08:00AM  
Sep-04-19 06:32AM  
Aug-27-19 08:00AM  
Aug-23-19 05:40AM  
Aug-14-19 04:30PM  
Aug-13-19 08:01AM  
Aug-09-19 08:30AM  
Aug-08-19 08:30AM  
Aug-06-19 10:30AM  
Aug-05-19 09:00AM  
07:31AM  
Jun-20-19 08:30AM  
May-29-19 04:17AM  
May-15-19 09:00AM  
08:00AM  
May-13-19 09:30AM  
08:44AM  
May-10-19 10:11AM  
10:00AM  
May-09-19 03:03PM  
11:05AM  
09:03AM  
May-08-19 05:00PM  
10:30AM  
May-07-19 05:50PM  
May-01-19 05:50PM  
Apr-26-19 11:11AM  
10:59AM  
09:30AM  
Apr-25-19 09:31AM  
Apr-17-19 08:14AM  
08:00AM  
Apr-16-19 07:26PM  
Apr-12-19 08:30AM  
08:00AM  
Apr-11-19 12:34PM  
Apr-08-19 08:43AM  
Apr-03-19 09:00AM  
Mar-29-19 08:00AM  
Mar-22-19 08:30AM  
Mar-04-19 08:30AM  
Feb-21-19 04:30PM  
Feb-01-19 07:30AM  
Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martinez Alberto R JrDirectorFeb 28Buy0.905,0004,50045,000Feb 28 10:50 AM
Martinez Alberto R JrDirectorNov 20Buy1.426,0008,52040,000Nov 20 11:28 AM
Fritz Frederick J.DirectorNov 06Buy1.3910,00013,87651,491Nov 07 08:33 AM
Martinez Alberto R JrDirectorNov 04Buy1.614,0006,44034,000Nov 04 02:40 PM